Mark Ordan is a real, identifiable public figure: Mark S. Ordan, currently Chair of the Board and CEO of Pediatrix Medical Group, and a longtime serial executive and entrepreneur with a career stretching from founding Fresh Fields Markets in the early 1990s to leading multiple publicly traded healthcare and real estate companies. The best available net worth estimate for him sits in a wide range, roughly $13 million to $55.8 million depending on the source and methodology, with most estimates derived from his disclosed SEC insider holdings rather than any confirmed personal financial statement. The honest answer is that no single verified figure exists publicly, but the SEC-based data gives us a reasonable floor.
Mark Ordan Net Worth: Estimate, Sources, and Verification Steps
Daniel Rothstein
9 Jul 2026
Who exactly is Mark Ordan?
This is worth spelling out clearly because the name could theoretically apply to more than one person. The Mark Ordan tracked across SEC filings, corporate board bios, and financial databases is Mark S. Ordan, based in Sunrise, Florida (1301 Concord Terrace, Sunrise, FL 33323 per SEC Form 4 filings). A Montgomery County Maryland public hearing transcript also lists Mark Ordan and his business address in Sunrise, Florida, providing an additional identity cross-check beyond SEC filings. He holds a BA in philosophy from Vassar College and an MBA from Harvard Business School. His public career is well-documented going back to a 1996 Washington Post article identifying him as president of Fresh Fields during its Whole Foods acquisition.
As of 2026, he is actively serving as Chair and CEO of Pediatrix Medical Group (formerly known as Mednax), a role he has held since January 2025, having previously served as CEO from July 2020 through December 2022. He also sits on the board of The Carlyle Group, with a Form 4 filed as recently as May 1, 2026 confirming active securities holdings there. He previously served as Chair of the U.S. Chamber of Commerce Board of Directors before being succeeded by Ross Perot Jr. If you found a different Mark Ordan in your search results, cross-check the Florida address, the Pediatrix/Mednax connection, and the Harvard MBA to confirm you have the right person before trusting any number.
What the best estimates actually say
Three financial data sources have published estimates, and they don't agree. Here's the picture:
| Source | Estimate | Date / As Of | Methodology |
|---|---|---|---|
| Benzinga | $49.1 million | Recalculated Sep 9, 2024 | Reported shares across multiple companies via SEC insider-trade data (CIK 0001208541) |
| Benzinga (updated) | $55.8 million | May 20, 2026 | Same SEC-insider methodology, refreshed calculation |
| GuruFocus | At least $8 million | July 7, 2026 | SEC filings, final shares after purchases/sales, no transactions assumed after Dec 15, 2025 |
| MarketScreener UK | $13 million | April 29, 2026 | Insider profile derived estimate |
The spread from $8 million to $55.8 million is large enough that you should treat all of these as rough approximations rather than financial facts. For the specific Markquis Nowell net worth question, use the same approach: focus on SEC-based holdings and disclosed compensation rather than one-off guesses estimate. The GuruFocus figure is explicitly labeled as a floor, not a ceiling, and the Benzinga figures fluctuate based on how they weight share prices at the time of calculation. None of these sources have access to his private assets, cash holdings, real estate equity, or proceeds from earlier business exits. For a practical working estimate, a range of $20 million to $55 million is reasonable, with moderate confidence that the true figure likely falls somewhere in that zone given his career arc.
How Mark Ordan built his wealth
The Fresh Fields story is the cornerstone. In 1991, Ordan and a partner raised $14 million to launch Fresh Fields, a natural and organic grocery chain. By 1996 they had grown it to 25 stores, at which point Whole Foods acquired the company for $150 million. That single transaction, as founder and president, would have been a meaningful wealth event. A formal Delaware merger certificate with his name on it is on file with the SEC, so this isn't legend, it's documented.
After Fresh Fields, Ordan moved into food retail again by taking over the Sutton Place Gourmet/Balducci's chain in 2003, backed by Bear Stearns Merchant Banking. He's described in a 2013 Washingtonian Business Hall of Fame profile as a turnaround specialist, someone who enters complicated or distressed businesses and restructures them, which is a recurring theme across his career rather than just one chapter.
His later career shifted into publicly traded company leadership: CEO of Sunrise Senior Living, CEO of The Mills Corporation (a major retail real estate company), CEO of Washington Prime Group, and CEO of Quality Care Properties, before landing at Pediatrix Medical Group. Each of these roles came with executive compensation packages including base salary, bonuses, and equity grants, all of which are disclosed in SEC proxy filings. The Carlyle Group board seat adds another layer of equity compensation and fees.
Current income streams
- CEO and Chair compensation at Pediatrix Medical Group (salary, annual bonus, stock awards)
- Board director fees and equity compensation from The Carlyle Group
- Returns from any retained equity or investments from prior executive roles
- Potential retained proceeds and investments from the Fresh Fields/Whole Foods transaction
- Any private investment activity not disclosed in public filings
Assets, lifestyle, and public signals
Ordan's professional address in Sunrise, Florida (the headquarters of Pediatrix Medical Group) is the clearest publicly documented location tied to him. His educational credentials (Vassar, Harvard Business School) and the caliber of boards he has served on, including the U.S. Chamber of Commerce at the chair level, signal a high-net-worth lifestyle consistent with a multi-decade career at the top of major companies, but there's no public disclosure of personal real estate holdings, vehicles, or personal investment accounts beyond what surfaces in SEC filings.
The SEC Form 4 filings are the most useful public window into his asset base. These disclose changes in his beneficial ownership of securities in Pediatrix and Carlyle. As of the most recent Benzinga calculation in May 2026, those reported share positions across multiple companies are the basis for the $55.8 million estimate. What's not captured there: private equity stakes, real estate, liquid cash from prior exits, or deferred compensation. So the insider-holdings estimates should genuinely be read as a partial snapshot.
Why the numbers vary so much
The gap between $8 million and $55.8 million isn't a sign that one source is lying. It reflects genuinely different methodologies and different moments in time. GuruFocus caps its calculation at December 15, 2025 and explicitly calls its figure a minimum, based on whatever share count was last filed. Benzinga uses a broader cross-company share aggregation that likely catches Carlyle holdings in addition to Pediatrix, which explains the much higher number. MarketScreener uses its own insider-profile algorithm that may weight differently again.
Stock prices also move. Pediatrix (ticker: MD) and Carlyle Group (CG) share prices fluctuate daily, so a calculation run in September 2024 will produce a different dollar figure than one run in May 2026 even if the share count hasn't changed. Neither number is wrong; they're just measuring different things at different times. This is a fundamental limitation of all SEC-derived net worth estimates, and it's worth keeping in mind anytime you see a precise-looking figure on a financial data site. If you are specifically trying to estimate Mark O Connor net worth, start from the SEC EDGAR disclosures and the latest proxy compensation tables net worth estimates.
None of these estimates account for private wealth. The Fresh Fields sale alone, at $150 million total proceeds in 1996, almost certainly left Ordan with a substantial personal windfall. How much of that was retained, reinvested, or deployed into subsequent ventures is unknown from public records. That single gap is probably the biggest reason his true net worth could exceed even the highest published SEC-based estimate. That private wealth gap is why Mark O Brien net worth numbers can be higher than the highest SEC-based figures you might see.
How to verify or research this yourself today
The most reliable primary source is SEC EDGAR. Search for CIK 0001208541 ("Ordan Mark S") directly at edgar.sec.gov to pull every Form 3, Form 4, and Form 5 he has filed. These show exactly which securities he owns and when he bought or sold them. A Form 4 filed May 1, 2026 via Carlyle's investor relations site confirms he is still an active filer as of this year.
- Go to edgar.sec.gov and search filings by the name "Ordan Mark S" or by CIK 0001208541 to access all insider ownership disclosures.
- Pull the most recent Form 4 filings for both Pediatrix Medical Group (ticker: MD, formerly Mednax) and The Carlyle Group (ticker: CG) to see current share counts.
- Cross-reference the current stock price for each company with his disclosed share count to estimate the market value of those specific holdings.
- Check Pediatrix's most recent DEF14A proxy filing on EDGAR for his annual executive compensation breakdown (salary, bonus, equity grants).
- Check The Carlyle Group's proxy filings for his board director compensation.
- Search Benzinga and GuruFocus for updated estimates, but note the methodology limitations each site discloses.
- For background verification of identity, the Pediatrix leadership page, U.S. Chamber of Commerce board bio, and the Washington Post 1996 archive piece all independently confirm the same individual.
Red flags to watch for: if you see a net worth figure for "Mark Ordan" that doesn't cite SEC filings or insider holdings as its basis, treat it as speculative. If you are specifically looking for Mark Donovan net worth figures, the most reliable approach is to start from SEC filings and then compare how each data site calculates its estimate. Tabloid-style celebrity net worth sites often copy figures from each other without updating them, and the number can be years out of date. Always check the "as of" date on any estimate you find.
Key updates to watch for
Ordan was appointed Chair and CEO of Pediatrix as recently as January 2025, so the full picture of his compensation in that combined role hasn't fully cycled through annual proxy filings yet. The first complete proxy covering that compensation package is worth pulling when Pediatrix files its next DEF14A, which would cover fiscal year 2025. That document will show exactly what he earned in salary, bonus, and equity during his first year as both chair and CEO.
His Carlyle Group board role also bears watching. Carlyle's board compensation for independent directors includes annual retainers and sometimes equity, and any new Form 4 filings under CIK 0001208541 will flag changes in those holdings. A March 2026 press release confirmed he was actively functioning as Pediatrix's CEO, so there's no sign of an imminent departure, but executive changes at the CEO level in any of his affiliated companies would move the net worth picture meaningfully.
Beyond Pediatrix and Carlyle, keep an eye on any new board appointments or venture announcements. Given his pattern of taking on distressed or complex business situations, it would be consistent with his career history to see him surface in another executive or advisory role, potentially with fresh equity grants that would shift his holdings. Any new Form 3 filing on EDGAR (which is required when an insider first acquires a stake in a new company) would be an early signal of that kind of move.
If you're researching the broader universe of notable Marks in business and finance, the methodology here, pulling SEC filings, checking proxy compensation tables, and cross-referencing career timelines, applies equally to executives like Mark Donovan or others in this space. The key is always to anchor the estimate to documented holdings and disclosed compensation rather than aggregator sites that recycle stale numbers.
FAQ
Why do Mark Ordan net worth estimates change so much between websites (for the same year)?
SEC-based figures typically use beneficial ownership reported in Form 4, then multiply by a specific stock price at the time the site ran the calculation. If you compare two estimates, align the “as of” date and share price used, otherwise you may think the number is inconsistent when it is mostly timing variance.
How can I verify which companies are included in a Mark Ordan net worth calculation?
Start with CIK 0001208541 and pull every Form 4, then check whether the Form 4 is for Pediatrix, Carlyle, or another issuer. Only after you confirm the issuers can you interpret a site’s total, because some aggregators include board-related positions while others include only the largest holdings.
Do net worth sites include Mark Ordan’s private investments and real estate, or just public stock holdings?
Many sites focus on public securities only, so they will miss private equity stakes, private company ownership, and real estate that is not held through a publicly traded vehicle. The article already notes this gap, so the practical takeaway is to treat any “net worth” number as a partial snapshot unless the source explicitly states it includes private assets.
Can Mark Ordan net worth go down even if he owns the same number of shares?
Not necessarily. If a calculator shows a lower number, it could reflect a decline in stock price or a different inclusion set (for example, excluding a smaller issuer or using an older share count). To decide whether “lower” is real, compare the latest Form 4 share totals alongside the stock prices used.
What are the red flags that a Mark Ordan net worth figure is unreliable or outdated?
If the estimate you found does not reference SEC filings or insider holdings, it is more likely a recycling of older figures or a guess based on compensation headlines. A quick check is whether it provides an “as of” date and whether the number can be reconciled with the most recent Form 4 positions.
Why doesn’t Mark Ordan’s reported compensation in proxies always match the net worth number shown by calculators?
Yes. Compensation shown in proxies and stock price-based valuations can lag each other. For example, equity grants may have been awarded in a proxy year but the reported beneficial ownership and market value will not fully reflect the grant until later when shares vest or are exercised and then appear in Form 4.
How should I interpret a very wide range, like $8 million to $55.8 million, for Mark Ordan net worth?
Treat it as “likely undercounted” rather than definitively wrong. SEC holdings-based methods miss cash from earlier exits, private asset value, and deferred or non-public components. So if you see a wide upper range, use it as a reminder of incompleteness, not as evidence that the insider snapshot is fabricated.
If I want the most current view, what should I check first on EDGAR for Mark Ordan?
Look for a recent Form 4 tied to a specific issuer and then check whether the filing shows an acquisition, disposition, or a change in beneficial ownership due to vesting or option exercise. A small change in holdings can produce a noticeable dollar swing if the stock price is volatile.
How do I make sure I’m looking at the net worth of the correct Mark Ordan and not a different person with the same name?
Cross-check identity before trusting the number. The article emphasizes the Florida address and the Pediatrix and Harvard MBA links; practically, confirm the same CIK across filings. If your “Mark Ordan” number is tied to a different CIK or a different location, the valuation is likely for someone else with a similar name.
What kinds of career or stock events are most likely to move Mark Ordan’s net worth estimate?
Watch for events that change the holdings base: new board seats with equity compensation, vesting of previously granted awards, and any option exercises or share sales. Each will show up in Form 4 timing, which is why monitoring new Form 4 filings is more useful than relying only on annual net worth articles.
Next Article
Mark O’Connor Net Worth: Which One and Estimate Sources
Clarifies which Mark O’Connor you mean and estimates net worth with income sources, assets, and uncertainty ranges.
